04/30/2024 4:26 PM | NRx Pharmaceuticals (Filer) NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/29/2024 3:46 PM | NRx Pharmaceuticals (Filer) NRX Pharmaceuticals, Inc. (Filer)
| Form 10-K/A | |
04/19/2024 4:10 PM | NRx Pharmaceuticals (Filer) NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/19/2024 9:08 AM | NRx Pharmaceuticals (Filer) NRX Pharmaceuticals, Inc. (Filer)
| Form 424B5 | |
04/18/2024 7:21 AM | NRx Pharmaceuticals (Filer) NRX Pharmaceuticals, Inc. (Filer)
| Form 424B5 | |
04/15/2024 4:22 PM | NRx Pharmaceuticals (Filer) NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/15/2024 4:13 PM | NRx Pharmaceuticals (Filer) NRX Pharmaceuticals, Inc. (Filer)
| Form 424B3 | |
|
04/15/2024 5:00 AM | NRx Pharmaceuticals (Filer) NRX Pharmaceuticals, Inc. (Filer)
| Form 424B3 | |
04/02/2024 5:01 AM | NRx Pharmaceuticals (Filer) NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/29/2024 4:18 PM | NRx Pharmaceuticals (Filer) NRX Pharmaceuticals, Inc. (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/21/2024 4:09 PM | NRx Pharmaceuticals (Filer) NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/13/2024 4:08 PM | NRx Pharmaceuticals (Filer) NRX Pharmaceuticals, Inc. (Filer)
| Form DEFA14A | |
03/11/2024 4:16 PM | NRx Pharmaceuticals (Filer) NRX Pharmaceuticals, Inc. (Filer)
| Form DEF 14A | |
02/28/2024 4:09 PM | NRx Pharmaceuticals (Filer) NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/28/2024 9:40 AM | NRx Pharmaceuticals (Filer) NRX Pharmaceuticals, Inc. (Filer)
| Form 424B5 | |
02/26/2024 4:15 PM | NRx Pharmaceuticals (Filer) NRX Pharmaceuticals, Inc. (Filer)
| Form 424B5 | |
02/14/2024 5:03 AM | NRx Pharmaceuticals (Filer) NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/02/2024 3:37 PM | NRx Pharmaceuticals (Filer) NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/23/2024 3:16 PM | NRx Pharmaceuticals (Filer) NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/16/2024 5:36 PM | NRx Pharmaceuticals (Issuer) NRX Pharmaceuticals, Inc. (Issuer) Rehnquist Janet (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
12/29/2023 3:30 PM | NRx Pharmaceuticals (Filer) NRX Pharmaceuticals, Inc. (Filer)
| Form PRE 14A | |
12/29/2023 3:15 PM | NRx Pharmaceuticals (Filer) NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/22/2023 3:30 PM | NRx Pharmaceuticals (Filer) NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K/A | |
11/22/2023 3:31 PM | NRx Pharmaceuticals (Filer) NRX Pharmaceuticals, Inc. (Filer)
| Form DEF 14A | |
11/22/2023 3:32 PM | NRx Pharmaceuticals (Filer) NRX Pharmaceuticals, Inc. (Filer)
| Form ARS | |
11/21/2023 4:23 PM | NRx Pharmaceuticals (Filer) NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/23/2023 3:05 PM | NRx Pharmaceuticals (Filer) NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/14/2023 3:04 PM | NRx Pharmaceuticals (Filer) NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/11/2023 8:19 AM | Gorovitz Aaron (Reporting) NRx Pharmaceuticals (Issuer) NRX Pharmaceuticals, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/11/2023 8:15 AM | Hurvitz Chaim (Reporting) NRx Pharmaceuticals (Issuer) NRX Pharmaceuticals, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/01/2023 3:48 PM | NRx Pharmaceuticals (Filer) NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/31/2023 4:18 PM | NRx Pharmaceuticals (Filer) NRX Pharmaceuticals, Inc. (Filer)
| Form 424B3 | |
08/31/2023 4:20 PM | NRx Pharmaceuticals (Filer) NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/24/2023 11:14 AM | Javitt Jonathan C (Reporting) NRx Pharmaceuticals (Issuer) NRX Pharmaceuticals, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/23/2023 8:24 AM | Javitt Jonathan C (Reporting) NRx Pharmaceuticals (Issuer) NRX Pharmaceuticals, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2023 4:10 PM | NRx Pharmaceuticals (Filer) NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/28/2023 4:15 PM | NRx Pharmaceuticals (Filer) NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/08/2023 9:21 AM | NRx Pharmaceuticals (Filer) NRX Pharmaceuticals, Inc. (Filer)
| Form 424B5 | |
06/07/2023 4:18 PM | NRx Pharmaceuticals (Filer) NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K/A | |
06/06/2023 3:27 PM | NRx Pharmaceuticals (Filer) NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/05/2023 7:00 AM | NRx Pharmaceuticals (Filer) NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
SHOCKING Crypto Leak… (Ad) A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products.
If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE…
The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
Claim your free seat by clicking here now. |